TY - JOUR
T1 - Adolescent nonalcoholic fatty liver disease and type 2 diabetes in young adulthood
AU - Bardugo, Aya
AU - Bendor, Cole D.
AU - Zucker, Inbar
AU - Lutski, Miri
AU - Cukierman-Yaffe, Tali
AU - Derazne, Estela
AU - Mosenzon, Ofri
AU - Tzur, Dorit
AU - Beer, Zivan
AU - Pinhas-Hamiel, Orit
AU - Ben-Ami, Michal
AU - Fishman, Boris
AU - Ben-Ami Shor, Dana
AU - Raz, Itamar
AU - Afek, Arnon
AU - Gerstein, Hertzel C.
AU - Häring, Hans Ulrich
AU - Tirosh, Amir
AU - Levi, Zohar
AU - Twig, Gilad
N1 - Publisher Copyright:
© 2020 The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Context: The long-term risk of type 2 diabetes in adolescents with nonalcoholic fatty liver disease (NAFLD) is unclear. Objective: To assess type 2 diabetes risk among adolescents with NAFLD. Design and Setting: A nationwide, population-based study of Israeli adolescents who were examined before military service during 1997-2011 and were followed until December 31, 2016. Participants: A total of 1 025 796 normoglycemic adolescents were included. Interventions: Biopsy or radiographic tests were prerequisite for NAFLD diagnosis. Data were linked to the Israeli National Diabetes Registry. Main Outcome Measures: Type 2 diabetes incidence. Results: During a mean follow-up of 13.3 years, 12 of 633 adolescents with NAFLD (1.9%; all with high body mass index [BMI] at baseline) were diagnosed with type 2 diabetes compared with 2917 (0.3%) adolescents without NAFLD. The hazard ratio (HR) for type 2 diabetes was 2.59 (95% confidence interval [CI], 1.47-4.58) for the NAFLD vs. the non-NAFLD group after adjustment for BMI and sociodemographic confounders. The elevated risk persisted in several sensitivity analyses. These included an analysis of persons without other metabolic comorbidities (adjusted HR, 2.75 [95% CI, 1.48-5.14]) and of persons with high BMI; and an analysis whose outcome was type 2 diabetes by age 30 years (adjusted HR, 2.14 [95% CI, 1.02-4.52]). The results remained significant when a sex-, birth year-, and BMI-matched control group was the reference (adjusted HR, 2.98 [95% CI, 1.54-5.74]). Conclusions: Among normoglycemic adolescents, NAFLD was associated with an increased adjusted risk for type 2 diabetes, which may be apparent before age 30 years.
AB - Context: The long-term risk of type 2 diabetes in adolescents with nonalcoholic fatty liver disease (NAFLD) is unclear. Objective: To assess type 2 diabetes risk among adolescents with NAFLD. Design and Setting: A nationwide, population-based study of Israeli adolescents who were examined before military service during 1997-2011 and were followed until December 31, 2016. Participants: A total of 1 025 796 normoglycemic adolescents were included. Interventions: Biopsy or radiographic tests were prerequisite for NAFLD diagnosis. Data were linked to the Israeli National Diabetes Registry. Main Outcome Measures: Type 2 diabetes incidence. Results: During a mean follow-up of 13.3 years, 12 of 633 adolescents with NAFLD (1.9%; all with high body mass index [BMI] at baseline) were diagnosed with type 2 diabetes compared with 2917 (0.3%) adolescents without NAFLD. The hazard ratio (HR) for type 2 diabetes was 2.59 (95% confidence interval [CI], 1.47-4.58) for the NAFLD vs. the non-NAFLD group after adjustment for BMI and sociodemographic confounders. The elevated risk persisted in several sensitivity analyses. These included an analysis of persons without other metabolic comorbidities (adjusted HR, 2.75 [95% CI, 1.48-5.14]) and of persons with high BMI; and an analysis whose outcome was type 2 diabetes by age 30 years (adjusted HR, 2.14 [95% CI, 1.02-4.52]). The results remained significant when a sex-, birth year-, and BMI-matched control group was the reference (adjusted HR, 2.98 [95% CI, 1.54-5.74]). Conclusions: Among normoglycemic adolescents, NAFLD was associated with an increased adjusted risk for type 2 diabetes, which may be apparent before age 30 years.
KW - Adolescence
KW - Adolescent
KW - NAFLD
KW - Non-alcoholic fatty liver disease
KW - Type 2 diabetes
KW - Young adults
UR - http://www.scopus.com/inward/record.url?scp=85099072915&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgaa753
DO - 10.1210/clinem/dgaa753
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 33075820
AN - SCOPUS:85099072915
SN - 0021-972X
VL - 106
SP - E34-E44
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 1
ER -